These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37110538)

  • 1. Innovative Metrics for Reporting and Comparing the Glycan Structural Profile in Biotherapeutics.
    Mastrangeli R; Satwekar A; Bierau H
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equivalence assessment of biotherapeutics with N- and O-glycosylation sites by sequential intact glycoform mass spectrometry (IGMS).
    Oh MJ; Kim U; Kim S; Cho DS; Seo JA; Seo N; An HJ
    J Pharm Biomed Anal; 2023 Sep; 234():115558. PubMed ID: 37393692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis and characterization of glycan pairing in therapeutic antibodies and Fc-containing biotherapeutics: Addressing current limitations and implications for N-glycan impact.
    Meudt M; Baumeister J; Mizaikoff B; Ebert S; Rosenau F; Blech M; Higel F
    Eur J Pharm Biopharm; 2024 Jul; 200():114325. PubMed ID: 38759899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.
    Zhu L; Guo Q; Guo H; Liu T; Zheng Y; Gu P; Chen X; Wang H; Hou S; Guo Y
    MAbs; 2014; 6(6):1474-85. PubMed ID: 25484062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycan analysis for protein therapeutics.
    Yang X; Bartlett MG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():29-40. PubMed ID: 31063953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoproteomics Technologies in Glycobiotechnology.
    Alagesan K; Hoffmann M; Rapp E; Kolarich D
    Adv Biochem Eng Biotechnol; 2021; 175():413-434. PubMed ID: 33205259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data-independent oxonium ion profiling of multi-glycosylated biotherapeutics.
    Madsen JA; Farutin V; Lin YY; Smith S; Capila I
    MAbs; 2018 Oct; 10(7):968-978. PubMed ID: 30067433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking the Behavior of Monoclonal Antibody Product Quality Attributes Using a Multi-Attribute Method Workflow.
    Jakes C; Millán-Martín S; Carillo S; Scheffler K; Zaborowska I; Bones J
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):1998-2012. PubMed ID: 33513021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific N-glycosylation analysis of human thyroid thyroglobulin by mass spectrometry-based Glyco-analytical strategies.
    Kayili HM; Salih B
    J Proteomics; 2022 Sep; 267():104700. PubMed ID: 35995381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Intact mass based multi-attribute method in support of mAb upstream process development.
    Lanter C; Lev M; Cao L; Loladze V
    J Biotechnol; 2020 May; 314-315():63-70. PubMed ID: 32294517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis.
    D'Atri V; Fekete S; Beck A; Lauber M; Guillarme D
    Anal Chem; 2017 Feb; 89(3):2086-2092. PubMed ID: 28208257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-glycan Analysis in Molecular Medicine: Innovator and Biosimilar Protein Therapeutics.
    Borza B; Hajba L; Guttman A
    Curr Mol Med; 2020; 20(10):828-839. PubMed ID: 33272172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-Specific N-glycosylation Analysis of Recombinant Proteins by LC/MS
    Canis K; Garénaux E; Boe JF
    Methods Mol Biol; 2021; 2271():133-154. PubMed ID: 33908005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrated Strategy Reveals Complex Glycosylation of Erythropoietin Using Mass Spectrometry.
    Guan Y; Zhang M; Gaikwad M; Voss H; Fazel R; Ansari S; Shen H; Wang J; Schlüter H
    J Proteome Res; 2021 Jul; 20(7):3654-3663. PubMed ID: 34110173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of N-glycan heterogeneities of erythropoietin products by liquid chromatography/mass spectrometry and multivariate analysis.
    Hashii N; Harazono A; Kuribayashi R; Takakura D; Kawasaki N
    Rapid Commun Mass Spectrom; 2014 Apr; 28(8):921-32. PubMed ID: 24623697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of NIST Monoclonal Antibody Reference Material Glycosylation Using the LC-MS/MS-Based Glycoproteomic Approach.
    Zhao J; Peng W; Dong X; Mechref Y
    J Proteome Res; 2021 Jan; 20(1):818-830. PubMed ID: 33196194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancies between High-Resolution Native and Glycopeptide-Centric Mass Spectrometric Approaches: A Case Study into the Glycosylation of Erythropoietin Variants.
    Čaval T; Buettner A; Haberger M; Reusch D; Heck AJR
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):2099-2104. PubMed ID: 33856811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of site-specific glycan heterogeneity on glycoproteins.
    Kolarich D; Jensen PH; Altmann F; Packer NH
    Nat Protoc; 2012 Jun; 7(7):1285-98. PubMed ID: 22678432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution.
    Zhang X; Reed CE; Birdsall RE; Yu YQ; Chen W
    SLAS Technol; 2020 Aug; 25(4):380-387. PubMed ID: 32458729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosimilarity assessment of biotherapeutics 1: Quantitative comparison of the N-glycosylation of the innovator and a biosimilar version of etanercept.
    Borza B; Szigeti M; Szekrenyes A; Hajba L; Guttman A
    J Pharm Biomed Anal; 2018 May; 153():182-185. PubMed ID: 29499461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.